NCT01748019View on ClinicalTrials.gov

ST1968 Intravenous (Weekly) in Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

December 31, 2011

Conditions
Solid Tumors
Interventions
DRUG

ST1968

ST1968 once a week for 2 weeks every 3 weeks (protocol amendment: once every 3 weeks

All Listed Sponsors
collaborator

Southern Europe New Drug Organization

OTHER

lead

sigma-tau i.f.r. S.p.A.

INDUSTRY

NCT01748019 - ST1968 Intravenous (Weekly) in Solid Tumors | Biotech Hunter | Biotech Hunter